Search Results - "Dyhl‐Polk, Anne"

Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review by Nur Husna, Siti Muhamad, Tan, Hern-Tze Tina, Mohamud, Rohimah, Dyhl-Polk, Anne, Wong, Kah Keng

“…Breast cancer is the global leading cause of cancer-related death in women and it represents a major health burden worldwide. One of the promising breast…”
Get full text

PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review by Stovgaard, Elisabeth Specht, Dyhl-Polk, Anne, Roslind, Anne, Balslev, Eva, Nielsen, Dorte

“…Purpose To systematically review the literature on the expression of PD-L1 in primary BC, variation of expression between subtypes and effect on overall…”
Get full text

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study by Dyhl‐Polk, Anne, Schou, Morten, Vistisen, Kirsten K., Sillesen, Anne‐Sophie, Serup‐Hansen, Eva, Faber, Jens, Klausen, Tobias W., Bojesen, Stig E., Vaage‐Nilsen, Merete, Nielsen, Dorte L.

“…Background Cardiotoxicity induced by 5‐fluorouracil (5‐FU) is well known but poorly understood. In this study, we undertook ECG recording (Holter) and analyses…”
Get full text

Wnt5a expression and prognosis in stage II–III colon cancer by Lund, Cecilia Margareta, Dyhl-Polk, Anne, Nielsen, Dorte Lisbeth, Riis, Lene Buhl

“…Cancer metastases accounts for most cancer deaths. The secreting glycoprotein Wnt5a impairs tumor cell migration and reduces invasiveness and metastasis. High…”
Get full text

Checkpoint inhibitors in pancreatic cancer by Henriksen, Andreas, Dyhl-Polk, Anne, Chen, Inna, Nielsen, Dorte

“…•Activity was not demonstrated with single-agent checkpoint inhibitors.•Combination therapy showed promise.•Overall, markedly response was not shown. Immune…”
Get full text

Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer by Mikkelsen, Marta Kramer, Lindblom, Nana Aviaja Frederikke, Dyhl-Polk, Anne, Juhl, Carsten Bogh, Johansen, Julia Sidenius, Nielsen, Dorte

“…Inflammation is an enabling characteristic of the hallmarks of cancer. There has therefore been increasing interest in the clinical value of circulating…”
Get full text

Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer by Dyhl-Polk, Anne, Vaage-Nilsen, Merete, Schou, Morten, Vistisen, Kirsten Kjeldgaard, Lund, Cecilia Margareta, Kümler, Thomas, Appel, Jon Michael, Nielsen, Dorte Lisbet

“…Fluoropyrimidines are mainstay chemotherapeutics in the treatment of gastrointestinal cancers and are also used to treat breast cancer and head and neck…”
Get more information

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma by Dyhl-Polk, Anne, Mikkelsen, Marta Kramer, Ladekarl, Morten, Nielsen, Dorte Lisbet

“…Introduction: Several immune checkpoint inhibitors (CPIs) are under clinical development in hepatocellular carcinoma (HCC) and the field is advancing rapidly…”
Get full text

ANTI-HER2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY OR CHEMOTHERAPY-FREE REGIMENS TARGETING HER2-POSITIVE BREAST CANCER: A SYSTEMATIC REVIEW by Nur Husna, Siti Muhamad, Hussain, Faezahtul Arbaeyah, Yahya, Maya Mazuwin, Dyhl-Polk, Anne, Wong, Kah Keng

“…Breast cancer is the leading cause of cancer-related death in female worldwide. Human epidermal growth factor receptor 2 (HER2) amplification is observed in…”
Get full text